PERFUSION SYSTEM MARKET ANALYSIS

Market News

For instance, in 2014, U.S. Food and Drugs Administration approved Xvivo Perfusion AB’s Xvivo Perfusion System (XPS) with STEEN solution, used in preserving initially unacceptable donor lungs while they are being evaluated as potentially viable transplantable organs. In February 2018, Paragonix Technologies, Inc. received approval for its new Paragonix SherpaPak Cardiac Transport System and SherpaPerfusion Cardiac Transport System in Europe. The SherpaPak Cardiac Transport System is used for the hypothermic static preservation and transport of donor hearts, and the SherpaPerfusion Cardiac Transport System consists of a single-use, disposable device for hypothermic oxygenated perfusion preservation and transport of donor hearts. The increasing investment by major key players in the market is also expected to fuel growth of the global perfusion system market in the near future. For instance, in January 2018, Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) raised around US$ 26.3 Mn as part of a Series D financing round. The raised amount will be used in the development and commercialization of PiCSO Impulse System.